[ad_1]
WEDNESDAY, Jan. 6, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover.
As an incentive to help boost the national convalescent plasma shortage, the Red Cross has teamed up with the National Football League and is offering donors a chance to win two tickets to next year’s Super Bowl LVI in Los Angeles.
The Red Cross is especially asking those who have recovered from COVID-19 to give blood because more donors are needed to help hospital patients.
Those who donate between Jan. 1 and 20 will be automatically entered to win the “Big Game at Home” package for viewing at home, with a 65-inch television and a $500 gift card.
People can schedule an appointment to give blood by visiting RedCrossBlood.org, using the Red Cross Blood Donor App, calling 1-800-RED-CROSS or activating the Blood Scheduling Skill for Amazon Alexa.
“While winter is historically a challenging time to collect blood due to the holidays and inclement weather, this year, COVID-19 has added a new challenge,” Dr. Pampee Young, chief medical officer of the American Red Cross, said in a news release.
“Last month, the Red Cross distributed the greatest number of convalescent plasma products than any other month during the pandemic. With hospital distributions for this product increasing about 250% since October, it is vital that those who have recovered from COVID-19 donate blood or plasma so that we can continue to treat those critically ill with the virus,” Young added.
COVID-19 survivors have a unique ability to make a difference in the lives of COVID-19 patients, according to the Red Cross. People who have recovered from COVID-19 may have antibodies in their plasma that could give a patient’s immune system the boost it needs to beat the virus.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
More News Resources
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
